| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XAIR | Common Stock | Sale | -$23.2K | -11.3K | -1.62% | $2.06 | 686K | Dec 28, 2023 | Direct | F1, F2 |
| transaction | XAIR | Common Stock | Sale | -$28.2K | -13.7K | -100% | $2.05 | 0 | Dec 28, 2023 | Held by Dandelion Investments Ltd. | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sale was made to satisfy an Israeli tax obligation related to the reporting person's investment in Beyond Air, Inc. and its majority-owned affiliate, Beyond Cancer, Ltd. |
| F2 | This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.075, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. |
| F3 | This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.0504 to $2.065, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4. |